Try our Advanced Search for more refined results
Life Sciences - June, 2012
261 articles
- Roche To Pay $18M Damages In Accutane Suit
- Care Providers Wary Of States Bucking Medicaid Expansion
- J&J Can't Shake False Ad Suit Over Bedtime Bath Products
- Device Cos. Face Slim Chance Of Tax Repeal After ACA Ruling
- HHS Unveils New Grants To Build State-Based Exchanges
- Acid Reflux Device Maker Beats Class Cert. In Row Over Ads
- Varian Again Loses Bid To Nix Pitt X-Ray Patent Ruling
- Law360's Global 20 Firms Open Up New Frontiers
- Endo Sues Noven To Protect The Market For Lidoderm
- Supreme Court Seeks SG's View In Claim Construction Case
- FDA Warns GSK's Zofran May Cause Abnormal Heart Rhythm
- With Ruling In Hand, Supreme Court Nixes ACA Challenges
- GSK, Human Genome Escalate $2.6B Buyout Battle
- Q&A With Katten's Robert Breisblatt
- Icahn Sues Forest Labs For Docs In Renewed Proxy Fight
- Christopher V. SmithKline: Impact On Pharma — And Beyond
- ACA Ruling Heats Up Already-Hopping Health Deals Scene
- Texas Insurance Exchange Debate Looms As ACA Upheld
- FDA Panel Calls For More Warnings On Metal Hip Implants
- 3rd Circ. Revives Suit Against GSK Over Avandia Injury Costs
- Calif. Dems Hail ACA Ruling While GOP Urges Caution
- In ACA Ruling, A Warning Not To Read High Court Tea Leaves
- Roberts Swing Vote On ACA Strikes A Conservative Balance
- Dissecting The Supreme Court Ruling On Health Care Reform
- BioSante Sued Again Over Female Libido Drug Disappointment
- Cuomo Hails High Court Health Ruling As NY GOPs Fume
- Pfizer Avoids Off-Label Marketing Suit Over Geodon, Zyvox
- Generic-Drug Users Can't Pin Brand-Name Cos., NJ Court Says
- GOP Vows Health Law Repeal, But Chances Are Slim For Now
- Ex-McDermott Atty Gets Theranos Trade Secrets Suit Trimmed
- Q&A With Seyfarth's Michel Feldman
- Health Care Ruling Brings Contract, Grant Opportunities
- High Court Limits On Medicaid Expansion May Be Moot
- Health Care Ruling Is Mixed Blessing For Insurers
- ACA Ruling To Spark More Investment In New Care Models
- Getting To A Rule For Reverse Payments
- Covidien Sales Reps' OT Suit Nixed By High Court GSK Ruling
- State Laggards Face Health Exchange Dilemma
- Biosimilars Dodge Bullet As High Court Upholds ACA
- With ACA Affirmed, Employers Must Prepare For 2014
- High Court Upholds Health Care Law Under Taxing Powers
- DePuy, Others Urge FDA Not To Lump Together Hip Implants
- Sandoz Takes Aim At Ranbaxy's Generic Nexium Sales Rights
- Firms Rev Up To Weigh In After Health Care Decision
- FDA Says Amylin Hid Diabetes Drug Safety Data
- Arena's Belviq 1st Obesity Drug To Get FDA's Nod Since 1999
- FDA Moves Forward On Study Of Drug Ad Offers
- USPTO Official Slams Use Of Compulsory Patent Licenses
- Q&A With Sills Cummis' Lori Waldron
- Ivera Expands IV Cap Patent War Against Hospira, Others
- Cumberland Tries To Shut Down Sagent's Generic Acetadote
- Expert Networking Exec Cops To Illegal Abaxis Tips
- FDA User Fee Bill Breezes Through Congress
- Amylin Board Hid $3.5B Offer To Buy Cheap Options: Suit
- Obama Vows Veto For Spending Bill That Shorts FDA By $700M
- Public Citizen Pushes FDA To Deny Diet Pill Approval
- W.Va. AG Sues 14 Drug Distributors Tied To Painkiller Abuse
- FDA Rips Covidien Response To Surgery Device Safety Issues
- Q&A With Dechert's George Gordon
- House GOP Targets AARP's Role In Health Care Reform Law
- The Role Of IP In Medical Device Investments
- Post-Mensing Landscape A Wasteland For Plaintiffs
- Bristol, Sanofi Sued Over Allegedly Deceptive Plavix Marketing
- Pfizer Sues 11 Rivals To Defend Pristiq Patent
- Mylan, Sandoz Infringed Teva's MS Drug Patents, Judge Finds
- Merck Pays $10M To Exit ERISA Class Action Over Vytorin
- $70M Novo Nordisk OT Suit Killed By High Court GSK Ruling
- Merck Hit With Antitrust Class Action Over Vaccine Data
- Metal Hip Implant Safety Studies Lacking, FDA Says
- FDA Again Delays Approval Of Pfizer-BMS Anti-Clotting Drug
- Medtronic Owes $7M In Device Royalties, University Says
- Q&A With Covington's Gerald Masoudi
- Justices Ask SG To Weigh In On GSK, Classen Patent Row
- Section 102: A Dead Letter For Qualifying Claims
- High Court Will Consider Medicare Repayment Deadlines
- High Court's Health Care Decision Expected Thursday
- Wis. High Court Upholds $13.5M Award Against Pfizer Unit
- Generics Cos. Escape From Darvocet, Darvon MDL
- FDA Tells Watson, Swedish Drugmaker To Pull Misleading Ads
- Smith & Nephew Says Sales Contractors Broke Noncompete
- GCs Name Law Firms With Top Shelf Brands
- FDA Hit With FOIA Suit Seeking Livestock Antibiotics Data
- Q&A With Oblon Spivak's Dan Pereira
- In Texas, The Learned Intermediary Doctrine Holds Steady
- Medical Device Cos. WL Gore, Cook Sued Over Stent Patents
- Allergan Requests Appeal Of Del. Botox Decision
- Abbott Can't Shake Roxane's Suit Over Generic Norvir
- FDA Supplement Guidance Likely To Remain Onerous, Attys Say
- Roche Ignored Drug Safety Reports, EU Watchdog Says
- Bristol-Myers Hits Sandoz Over Generic Hepatitis Drug
- Whistleblowers Say Merck Falsified Mumps Vaccine Data
- Email Monitoring Can Be Illegal, OSC Tells Federal Agencies
- FDA To Lower Risk Category For Hemodialysis Devices
- FDIC Says Forged Inyx Docs Support $25M Westernbank Claim
- Determining A Product's Defect By Its Primary Use
- EU Data Protection — Implications For Clinical Studies
- Q&A With Foley & Lardner's Antoinette Konski
- Medtronic Trumps Gore's Stent Graft Patent Claims
- J&J Can't Get New Trial Over $1.2B Ark. Risperdal Fine
- GOP Moves To Block IRS Premium Tax Credit Rule
- Joint Ventures In China: What Every CEO Should Know
- Merck Accused Of Using 'Madagascar 3' To Illegally Target Kids
- FDA Panel Endorses Onyx Pharmaceuticals' Blood Cancer Drug
- FDA User Fee Bill Keeps Rocketing Through Congress
- Buchanan Injects Health Team With Pair Of Shareholders
- Q&A With Roetzel's Michael Keller
- Boston Scientific Stents Again Beat J&J Infringement Claims
- FDA Panel Won't Back Sanofi Blood Thinner For Cancer Patients
- Drugmakers Find Much To Love In Final FDA Reform Bill
- Disbarred Attys Must Forfeit Assets Over Fen-Phen Fees
- Drug Rep Ruling May Give Employers More Ammo In OT Suits
- Pfizer Storing Up $330M To Settle Menopause Drug Suits
- Union Health Plan Sues Merck Over Drug Copay Subsidies
- Judge Certifies Limited Class In Flonase Antitrust Action
- Sens. Pressure High Court To Televise Health Law Decision
- Biz Leaders Urge Cool-Off Period After Health Care Ruling
- USPTO Says Novartis' Patent Term Case Is Time-Barred
- Q&A With Drinker Biddle's Jesse Witten
- GE Says Cybersquatting Ultrasound Dealer Infringes Marks
- Tackling A Circuit Splitter: Amgen In The High Court
- 'Regulation By Amicus' No Longer An Option For Agencies
- Myriad, ACLU Argue Over Prometheus In Gene Patent Battle
- US Defends Pharmacy Price Caps For Vets To DC Circ.
- Industry-Backed Drug Tracking System Gone From FDA Bill
- Drug Theft, Counterfeiting Bills Would Garner Few Cases: CBO
- EU Breast Implant Study Won't Help Litigation Targets
- Novartis, Others Win $400M In HHS Vaccine Center Contracts
- Q&A With Arnold & Porter's Dan Kracov
- Proskauer Keeps Grip On Client Docs In $20M Malpractice Suit
- High Court Deems GSK Drug Sales Reps OT-Exempt
- FDA Probe Could Grow To Encompass Fresenius Empire
- Apotex Did Not Infringe On Merck's Nasonex Patent: Judge
- Wyeth Can't Kick Class Cert. In Canadian Suit Over Premarin
- Head Of ACA Implementation To Step Down From Post
- K&L Gates Adds Product Liability Team In Orange County
- Statehouse The Place To Tackle AG Fee Deals, Experts Say
- Q&A With Fulbright's Lana Varney
- Skadden Steers Valeant To $312M Deal For Oral Care Co.
- Janssen Sues Mylan, Others To Block Generic Prezista
- St. Jude Stock Flatlined Amid Recalls, Investors Say
- Health Care Ruling Could Mean Years Of Delay For Biosimilars
- Fed. Circ. Won't Rethink Standing In Myriad Gene Patent Case
- Sens. Pass $159B Bill Sans NLRB, ACA Defunding Measures
- Fed. Circ. Makes It Harder To Prove Willful Infringement
- EU Lawmakers Push For Tougher Breast Implant Standards
- Merck Wins Dismissal Of Vioxx False Claims Suit From MDL
- Ceragenix Whistleblower's Malpractice Suit Shut Down
- FDA Panel Backs Edwards Heart Valve For Wider Use
- Biotronik Tangles With St. Jude Over Sales Rep Noncompete
- Q&A With Drinker Biddle's Robyn Shapiro
- Lights, Camera, Courtroom: Lessons From Mike Wallace
- Novartis Defeats Appeal To Bone Drug Bellwether Ruling
- Pfizer Battles 2nd FCA Suit Over Antifungal Drug Promotions
- Firm Sued Over Fees To Preempt Malpractice Claims: Lab Co.
- Univ. of Utah's RNA Patent Suit Survives Challenge
- Report Fingers 2nd St. Jude Device For In-Body Wire Failure
- GSK Says ERISA Suit Dismissal Backed By 6th Circ. Ruling
- Wolf Greenfield Lands IP Pros From Kirkland, WilmerHale
- Q&A With Katten's Brian Sodikoff
- Payors Urge 1st Circ. To Revive Pfizer Neurontin MDL Claims
- Upsher-Smith To Pay £223M For UK Drug Co. Proximagen
- Another Approach To The Unsafe Product Exclusion
- CVS, Rite Aid Latest To Sue Wyeth, Teva Over Effexor
- Panel OKs Bill To Align Calif. False Claims Law With US Law
- $159B Bill Advances Over GOP Protests Of ACA Funding
- China's Compulsory License Rule Has Drug Cos. On Edge
- High Court's Amgen Ruling Could Stymie Securities Classes
- Lilly Adds $20M To Investment In Chinese Drugmaker
- NY Enlists Docs, Pharmacists In Rx Drug Crackdown
- FTC Blasts Androgel Pay-For-Delay Ruling In 11th Circ.
- Novartis Asks 4th Circ. To Block $1M Aredia, Zometa Verdict
- Troutman Adds McDermott Life Sciences IP Quartet In NY
- GSK To Hand Over $227M For Basilea Eczema Drug
- FSMA's Potential Impact, Part 2: Title And Risk Of Loss
- Q&A With Axinn Veltrop's Jeremy Lowe
- ACLU Defends Standing Of Lone Gene Patent Plaintiff
- RyMed Wins Catheter Row After USPTO Nixes Rival's Patent
- Edwards Valve Comparable To Traditional Surgery, FDA Says
- J&J Dumps Wrist Device IP To Clear Way For $21B Synthes Buy
- Cooley Adds Partner To Growing Shanghai Office
- Allergan Can't Kick Investor Suit Over $600M Botox Settlement
- Savient Denies Default In Countersuit Against Creditor
- Greenberg Adds Health Dealmaker To Orange County Office
- Q&A With Akin Gump's Mark Mansour
- FDA Warnings Can Be Fought In Court, Supreme Court Told
- Hospitals Call For Drug Shortage Fines In FDA Bill
- High Court To Weigh In On Amgen Class Cert. Quarrel
- J&J Announces $600M Hit To Pay For Drug Settlements
- Texas High Court Adopts Intermediary Rule In Drug Cases
- Struggling Savient Swipes Creditors' Bid To Appoint Receiver
- FDA Mulls Stricter Controls To Curb Hydrocodone Abuse
- Feds Ignore Lessons Of GSK Obstruction Case, Attys Say
- GOP Says Obama Aides Helped Run ACA Ad Campaigns
- Genentech, UPenn End Herceptin Patent Row On Eve Of Trial
- Gilead Stalled On HIV Prevention Approval For Truvada
- Sens. Call For Tighter Reins On Prescription Painkillers
- Mylan, Teva Settle Over Generic Provigil Market Rights
- Q&A With Debevoise's Kevin Rinker
- GSK Extends $2.6B Offer For Human Genome
- Generics Industry Pushes Congress On Brand-Name Samples
- CR Bard Picks Up Bellwether Win In Vein Filter Defect Suit
- Device Tax Repeal Previews Fight Over Health Law Deals
- Medicis Sues To Block Zydus' Generic Acne Treatment
- Abbott Asks Calif. Judge To Toss B&L Suit Over Noncompetes
- Orthofix To Pay $42M To End Kickback, Medicare Fraud Claims
- Pfizer Begins Spinoff Of Animal Health Business
- Q&A With Robins Kaplan's Jake Holdreith
- Connecting Off-Label Marketing To Use: Not Quite A To B
- Lawmakers Train Fire On VA's Drug Acquisition Practices
- FCC Chief Targets Barriers To Wireless Medical Technology
- Obama May Veto Threat To PPACA's Health Device Tax
- 6th Circ. Lets Novartis Off Hook In Bone Drug Liability Suit
- Doctors Don't Properly Store Kids' Vaccines, HHS Says
- Woman-Owned Firm Scharf Makes Independent Debut
- Masimo Says Indian Medical Device Co. Misled TED Audience
- High Court Health Ruling Won't Transform System, Execs Say
- Stryker Offers $33M To End DOJ Probe Into Knee Product
- FDA Must Strengthen Reviews For Risky Devices: FDA Head
- Quinn Emanuel Brings On Jones Day Pharma Patent Trio
- Q&A With Morgan Lewis' Steve Mahinka
- Tripping Up Defendants With Bootstrap Reasoning
- Mich. Courts Can't Nix Policy Limits Automatically: 6th Circ.
- Merck Targets Sandoz, Intas Over Generic Emend Plans
- For Biosimilars, Profit's All In A Name
- FDA Warns Siemens Over Biochemical Device Design
- 9th Circ. Voices Doubt On $60M NuVasive Trademark Award
- Kardashians Say They Aren't At Fault For False Diet Pill Ads
- J&J Tells Judge It Will Stop Selling Vaginal Implants
- FDA Must Act On Livestock Antibiotics, Judge Says
- FDA Should Boost Training For Device Reviewers: Report
- GE Healthcare Grabs Brazilian X-Ray Systems Maker
- 3rd Circ. Strips Hospitals Of Standing In Becton Antitrust Suit
- Pfizer Boosts Quigley Asbestos Funds In New Ch. 11 Plan
- Nelson Mullins Snags Health Care Partner From Pillsbury
- For Whom The Court Tolls
- Q&A With Baker Botts' Sandra Lee
- 8th Circ. Reinstates Investors' Claims Against KV Pharma
- Jury Clears J&J In Rembrandt Contact Lens Patent Row
- Smith & Nephew Hip Problems May Persist Beyond Recall
- Hogan Bolsters Health Practice With Capitol Hill Vet
- Health Groups Want Deadline For Long-Stalled Device Rules
- Greenberg Grabs International M&A Atty for Philly Office
- Judge Trims $421M Medicaid Kickback Suit Against Organon
- Abbott Targets Kremers Over Niaspan Clone
- Q&A With O'Melveny's David Deaton
- Judge Could Deal Out Fines In Vitamin C Antitrust MDL
- 8 Trends In Venture Capital 2012
- Pfizer, Monsanto Lose Bid For Contributions To $600M Cleanup
- Legal Considerations For mHealth Stakeholders
- Ceragenix Atty Sued Over Whistleblower's Ouster
- Drug Promoters Say Genentech Shorted Them On OT
- FDA Warns Of Harmful Unlisted Drugs In Mexican Supplement
- Judge Grants New Trial In $212M Allergan Botox Suit
- Pharmacists Urge Congress Not To Restrict Hydrocodone Use
- 8th Circ. Absolves Drugmakers In Mirapex Liability Suit
- Masimo Hit With IP Suit Over Blood-Testing Technology
- Graceway Trustee Slams Distributor's Bid To Cut Debt
- J&J Wins Reversal Of Expert Restriction In Pelvic Mesh Suits
- Pharmacists Ask FDA For Biosimilar Substitution Power
- Judge Upholds PharmAthene-SIGA Smallpox Drug Profit Share
- Q&A With Cravath's David Greenwald